Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.

Cabello-Olmo M, Araña M, Radichev I, Smith P, Huarte E, Barajas M.

Int J Mol Sci. 2019 Sep 26;20(19). pii: E4789. doi: 10.3390/ijms20194789. Review.

2.

Transgenic Tumor Models for Evaluating CAR T-Cell Immunotherapies.

Aranda F, Barajas M, Huarte E.

Curr Protoc Pharmacol. 2019 Sep;86(1):e66. doi: 10.1002/cpph.66.

PMID:
31539924
3.

Gut microbiota metabolites for sweetening type I diabetes.

Aljutaily T, Consuegra-Fernández M, Aranda F, Lozano F, Huarte E.

Cell Mol Immunol. 2018 Feb;15(2):92-95. doi: 10.1038/cmi.2017.65. Epub 2017 Jul 31. No abstract available.

4.

Regulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune Encephalomyelitis.

Huarte E, Jun S, Rynda-Apple A, Golden S, Jackiw L, Hoffman C, Maddaloni M, Pascual DW.

J Immunol. 2016 Jun 15;196(12):5036-46. doi: 10.4049/jimmunol.1501973. Epub 2016 May 18.

5.

Influence of heat treatment on antioxidant capacity and (poly)phenolic compounds of selected vegetables.

Juániz I, Ludwig IA, Huarte E, Pereira-Caro G, Moreno-Rojas JM, Cid C, De Peña MP.

Food Chem. 2016 Apr 15;197(Pt A):466-73. doi: 10.1016/j.foodchem.2015.10.139. Epub 2015 Oct 29.

6.

Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes.

Soysal SD, Muenst S, Kan-Mitchell J, Huarte E, Zhang X, Wilkinson-Ryan I, Fleming T, Tiriveedhi V, Mohanakumar T, Li L, Herndon J, Oertli D, Goedegebuure SP, Gillanders WE.

Breast Cancer Res Treat. 2014 Oct;147(3):527-37. doi: 10.1007/s10549-014-3129-x. Epub 2014 Sep 12.

7.

Helper cell-independent antitumor activity of potent CD8+ T cell epitope peptide vaccines is dependent upon CD40L.

Llopiz D, Huarte E, Ruiz M, Bezunartea J, Belsúe V, Zabaleta A, Lasarte JJ, Prieto J, Borrás-Cuesta F, Sarobe P.

Oncoimmunology. 2013 Dec 1;2(12):e27009. Epub 2013 Dec 5.

8.

Gene expression profile of peripheral blood lymphocytes from renal cell carcinoma patients treated with IL-2, interferon-α and dendritic cell vaccine.

Wolf B, Schwarzer A, Côté AL, Hampton TH, Schwaab T, Huarte E, Tomlinson CR, Gui J, Fisher JL, Fadul CE, Hamilton JW, Ernstoff MS.

PLoS One. 2012;7(12):e50221. doi: 10.1371/journal.pone.0050221. Epub 2012 Dec 3.

9.

Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE.

Huarte E, Rynda-Apple A, Riccardi C, Skyberg JA, Golden S, Rollins MF, Ramstead AG, Jackiw LO, Maddaloni M, Pascual DW.

J Autoimmun. 2011 Dec;37(4):328-41. doi: 10.1016/j.jaut.2011.09.005. Epub 2011 Oct 22.

10.

Murine and bovine γδ T cells enhance innate immunity against Brucella abortus infections.

Skyberg JA, Thornburg T, Rollins M, Huarte E, Jutila MA, Pascual DW.

PLoS One. 2011;6(7):e21978. doi: 10.1371/journal.pone.0021978. Epub 2011 Jul 12.

11.

Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression.

Skyberg JA, Robison A, Golden S, Rollins MF, Callis G, Huarte E, Kochetkova I, Jutila MA, Pascual DW.

J Leukoc Biol. 2011 Dec;90(6):1043-54. doi: 10.1189/jlb.0311168. Epub 2011 Jun 21.

12.

Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.

Rynda-Apple A, Huarte E, Maddaloni M, Callis G, Skyberg JA, Pascual DW.

Eur J Immunol. 2011 Feb;41(2):313-23. doi: 10.1002/eji.201041104. Epub 2010 Dec 29.

13.

[Intra-dialysis parenteral nutrition in chronic renal patients: consensus SEN-SENPE].

García de Lorenzo A, Arrieta J, Ayúcar A, Barril G, Huarte E; Sociedad Española de Nefrología; Sociedad Española de Nutrición Parenteral y Enteral.

Nutr Hosp. 2010 May-Jun;25(3):375-7. Spanish.

PMID:
20593117
14.

Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma.

Huarte E, Fisher J, Turk MJ, Mellinger D, Foster C, Wolf B, Meehan KR, Fadul CE, Ernstoff MS.

Cancer Lett. 2009 Nov 18;285(1):80-8. doi: 10.1016/j.canlet.2009.05.003. Epub 2009 Jun 6.

15.

Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.

Durántez M, López-Vázquez AB, de Cerio AL, Huarte E, Casares N, Prieto J, Borrás-Cuesta F, Lasarte JJ, Sarobe P.

Scand J Immunol. 2009 Feb;69(2):80-9. doi: 10.1111/j.1365-3083.2008.02202.x. Epub 2008 Dec 10.

16.

Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity.

Huarte E, Cubillos-Ruiz JR, Nesbeth YC, Scarlett UK, Martinez DG, Buckanovich RJ, Benencia F, Stan RV, Keler T, Sarobe P, Sentman CL, Conejo-Garcia JR.

Cancer Res. 2008 Sep 15;68(18):7684-91. doi: 10.1158/0008-5472.CAN-08-1167. Epub 2008 Sep 3.

17.

PILAR is a novel modulator of human T-cell expansion.

Huarte E, Cubillos-Ruiz JR, Nesbeth YC, Scarlett UK, Martinez DG, Engle XA, Rigby WF, Pioli PA, Guyre PM, Conejo-Garcia JR.

Blood. 2008 Aug 15;112(4):1259-68. doi: 10.1182/blood-2007-12-130773. Epub 2008 Jun 12.

18.

The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFN gamma.

Arina A, Murillo O, Hervás-Stubbs S, Azpilikueta A, Dubrot J, Tirapu I, Huarte E, Alfaro C, Pérez-Gracia JL, González-Aseguinolaza G, Sarobe P, Lasarte JJ, Jamieson A, Prieto J, Raulet DH, Melero I.

Int J Cancer. 2007 Sep 15;121(6):1282-95.

19.

[The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases].

Alfaro C, Murillo O, Tirapu I, Azpilicueta A, Huarte E, Arina A, Arribillaga L, Pérez-Gracia JL, Bendandi M, Prieto J, Lasarte JJ, Melero I.

An Sist Sanit Navar. 2006 Jan-Apr;29(1):77-96. Review. Spanish.

20.

Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.

Huarte E, Larrea E, Hernández-Alcoceba R, Alfaro C, Murillo O, Arina A, Tirapu I, Azpilicueta A, Hervás-Stubbs S, Bortolanza S, Pérez-Gracia JL, Civeira MP, Prieto J, Riezu-Boj JI, Melero I.

Mol Ther. 2006 Jul;14(1):129-38. Epub 2006 Apr 19.

21.

Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma.

Tirapu I, Huarte E, Guiducci C, Arina A, Zaratiegui M, Murillo O, Gonzalez A, Berasain C, Berraondo P, Fortes P, Prieto J, Colombo MP, Chen L, Melero I.

Cancer Res. 2006 Feb 15;66(4):2442-50.

22.

Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8.

Feijoó E, Alfaro C, Mazzolini G, Serra P, Peñuelas I, Arina A, Huarte E, Tirapu I, Palencia B, Murillo O, Ruiz J, Sangro B, Richter JA, Prieto J, Melero I.

Int J Cancer. 2005 Aug 20;116(2):275-81.

23.

Intratumoural administration of dendritic cells: hostile environment and help by gene therapy.

Huarte E, Tirapu I, Arina A, Vera M, Alfaro C, Murillo O, Palencia B, Busto V, Marín V, Mazzolini G, Melero I.

Expert Opin Biol Ther. 2005 Jan;5(1):7-22. Review.

24.

HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones.

Huarte E, Karbach J, Gnjatic S, Bender A, Jäger D, Arand M, Atanackovic D, Skipper J, Ritter G, Chen YT, Old LJ, Knuth A, Jäger E.

Cancer Immun. 2004 Dec 16;4:15.

25.

Carcinoembryonic antigen as a target to induce anti-tumor immune responses.

Sarobe P, Huarte E, Lasarte JJ, Borrás-Cuesta F.

Curr Cancer Drug Targets. 2004 Aug;4(5):443-54. Review.

26.

Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen.

Kobayashi H, Omiya R, Ruiz M, Huarte E, Sarobe P, Lasarte JJ, Herraiz M, Sangro B, Prieto J, Borras-Cuesta F, Celis E.

Clin Cancer Res. 2002 Oct;8(10):3219-25.

27.

Enhancing immunogenicity of a CTL epitope from carcinoembryonic antigen by selective amino acid replacements.

Huarte E, Sarobe P, Lu J, Casares N, Lasarte JJ, Dotor J, Ruiz M, Prieto J, Celis E, Borrás-Cuesta F.

Clin Cancer Res. 2002 Jul;8(7):2336-44.

28.

Identification of HLA-B27-restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigen.

Huarte E, Sarobe P, Lasarte JJ, Brem G, Weiss EH, Prieto J, Borrás-Cuesta F.

Int J Cancer. 2002 Jan 1;97(1):58-63.

29.

Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.

Sarobe P, Huarte E, Lasarte JJ, López-Díaz de Cerio A, García N, Borrás-Cuesta F, Prieto J.

J Hepatol. 2001 Feb;34(2):321-9.

30.

Specific and general HLA-DR binding motifs: comparison of algorithms.

Borrás-Cuesta F, Golvano J, García-Granero M, Sarobe P, Riezu-Boj J, Huarte E, Lasarte J.

Hum Immunol. 2000 Mar;61(3):266-78.

PMID:
10689116
31.

Decreased excretion of nitrate and nitrite in essential hypertensives with renal vasoconstriction.

Sierra M, Gonzalez A, Gomez-Alamillo C, Monreal I, Huarte E, Gil A, Sanchez-Casajus A, Díez J.

Kidney Int Suppl. 1998 Dec;68:S10-3.

PMID:
9839276
32.

Vasoconstriction of the afferent arteriole and defective renal synthesis of nitric oxide in essential hypertension.

Gómez-Alamillo C, Sanchez-Casajús A, Sierra M, Huarte E, Díez J.

Kidney Int Suppl. 1996 Jun;55:S129-31.

PMID:
8743533
33.
34.

Glomerular nephropathy associated with chronic Q fever.

Perez-Fontan M, Huarte E, Tellez A, Rodriguez-Carmona A, Picazo ML, Martinez-Ara J.

Am J Kidney Dis. 1988 Apr;11(4):298-306.

PMID:
3354566
35.

Mycobacterium chelonei peritonitis due to hematogenous dissemination in a continuous ambulatory peritoneal dialysis patient.

Selgas R, Muñoz J, Aquella A, Huarte E, Fonseca E, Escuin F, Contreras F.

Am J Kidney Dis. 1987 Aug;10(2):144-6.

PMID:
3605092
36.

[Pancreatic beta cell function in patients treated with continuous ambulatory peritoneal dialysis. Its evolution in time and its relation with metabolic complications].

Selgas R, Albero R, Muñoz J, Grande C, Beberide JM, Huarte E, Fontán MP, Miguel JL, Torre A, Sicilia LS.

Med Clin (Barc). 1985 Oct 19;85(12):491-4. Spanish. No abstract available.

PMID:
3908845
37.

[Clinical presentation and prognostic factors in accelerated arterial hypertension. Review of 29 cases].

Pérez Fontán M, Escuín F, Huarte E, Miguel JL, Selgas R, Rodríguez-Carmona A, Torre A, Sánchez Sicilia L.

Med Clin (Barc). 1984 Dec 1;83(18):747-51. Spanish. No abstract available.

PMID:
6521537
38.

[Prevention of peritonitis in continuous ambulatory peritoneal dialysis. Comparative study of 2 different protocols of training and bag changing].

Selgas R, Pérez-Fontán M, Miguel JL, Rodríguez-Carmona A, Zuzuarregui MS, Escuin F, Ortega O, Conesa J, Huarte E, Sánchez Sicilia L.

Med Clin (Barc). 1984 Oct 20;83(12):482-4. Spanish. No abstract available.

PMID:
6513621

Supplemental Content

Loading ...
Support Center